Potential anticancer effect of free and nanoformulated Deferasirox for breast cancer treatment: < em > in-vitro < /em > and < em > in-vivo < /em > evaluation

CONCLUSION: The newly developed DFX nanoform demonstrated a high potential as a promising therapeutic agent for BC treatment.PMID:38305197 | DOI:10.1080/03639045.2024.2314189

Source: Drug Development and Industrial Pharmacy - February 2, 2024 Category: Drugs & Pharmacology Authors: Nadeen Diaa Abdel-Wahab Mohamed Fawzi Kabil Ibrahim M El-Sherbiny Mohamed F Salama Gehad El-Sayed El-Said El-Sherbini Source Type: research